Latest News & Updates
Breaking News
1 hour ago
Pharma Now Editorial Team
Dyne Therapeutics Submits BLA for Z-Rostudirsen After DELIVER Trial Meets Dystrophin Endpoints
Pharma Now Editorial Team
Other trending news you may like to read
AbbVie Gains FDA Approval for Decnupaz in Ultra-Rare Hematologic Malignancy BPDCN
AbbVie's Decnupaz gains FDA approval for BPDCN, raising GMP and CMC compliance priorities for ADC manufacturers and QA teams.
Pharma Now Editorial Team
Zentalis Appoints Shannon Campbell and Sarah Kelly to Build Commercial Infrastructure for Azenosertib Launch
Zentalis adds Shannon Campbell to its board and Sarah Kelly as SVP of Commercial Strategy as azenosertib advances through registrational trials.
Pharma Now Editorial Team
Dyne Therapeutics Submits BLA for Z-Rostudirsen After DELIVER Trial Meets Dystrophin Endpoints
Dyne Therapeutics files a BLA for z-rostudirsen under accelerated approval, while Sartorius opens a €140M CGT manufacturing center in Germany.
Pharma Now Editorial Team
FDA Finalizes ICH M7(R2) Guidance on Mutagenic Impurity Assessment and Acceptable Intake Calculations
FDA finalizes ICH M7(R2) guidance on mutagenic impurity control, updating acceptable intake calculations and harmonizing global assessment standards.
Pharma Now Editorial Team
